【ChiCTR-TRC-12002535】A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community
ChiCTR-TRC-12002535
结束
/
/
/
2012-09-28
/
/
Chronic Insomnia
A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community
A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community
Nil
The aim of the current proposed study is to evaluate the effectiveness of MBCT in treating primary chronic insomnia in primary care by comparison with a psycho-education control (PEC) group. The research questions are as follows: 1. Can MBCT improve sleep efficiency, sleep latency, time awake after sleep onset and total sleep time in those who suffer from chronic insomnia when compared to a psycho-education control group? 2. Is MBCT effective in reducing health service utilization in patients with chronic insomnia (including utilization of primary care services e.g. private doctor consultation, Accident and Emergency utilization and general outpatient utilization) when compared to a psycho-education control group? We hypothesize that patients who have been randomized to the MBCT group would show greater improvements on sleep latency, time awake after sleep onset, and sleep efficiency when compared to a psycho-education control group. We also hypothesize that patients in the MBCT condition would have a greater reduction in health service use than patients in the psycho-education control group.
随机平行对照
其它
This generation of random numbers and assignment will be performed by a statistician who is not part
The research staff to be employed for this study includes 1 full time senior research assistant (master degree with 4 year relevant experience). He/she will also be responsible for conducting the baseline interviews, blinded assessment of patients’ health service utilization and visits to health care professionals, and blinded assessment of patient’s outcome survey
Research Fund for the Control of Infectious Diseases Health and Health Services Research Fund
/
214
/
2012-10-13
2014-10-14
/
1. being 18 years of age or older; 2. having, at baseline assessment, chronic insomnia based on established criteria (DSM IV and ICD-10 combined) that include: (1) difficulties initiating and/or maintaining sleep, defined as a sleep onset latency and /or wake after sleep onset greater than 30 minutes, with a corresponding sleep time of less than 6.5 hours at least 3 nights per week as measured by daily sleep diaries; (2) duration of longer than 6 months and c) significant impairment of daytime functioning (rating of >=2 on item 5 of the Insomnia Severity Index [ISI]; 3. can understand Cantonese; 4. are willing to attend the mindfulness-based cognitive therapy program; 5. are willing to discontinue their sleep medications for a period of 2 weeks (washout period) prior to enrolling in the study or agree to keep constant the dosage and frequency of sleep medication during the study period among those who regularly use sleep medications.;
请登录查看1. illiterate subjects as they will not be able to complete the meditation diary or PEC work sheet and questionnaires; 2. psychiatric and medical co-morbidities that are potentially life threatening (i.e. psychosis, suicidal ideation, terminal medical illness) or conditions expected to severely limit patient participation or adherence (e.g. psychosis, current substance or alcohol abuse, dementia, pregnancy); 3. presence of a progressive medical illness such as dementia that is directly related to the onset and course of insomnia; 4. screened positive for major depression, eating disorder, substance abuse or anxiety disorder using the Primary Health Questionnaire (PHQ); 5. presence of psychotic symptoms or disorder; 6. night shift work; 7. those already using cognitively behavioural therapy or are planning to start cognitive behavioural therapy.;
请登录查看JC School of Public Health and Primary Care, the Chinese University of Hong Kong
Nil
JC School of Public Health and Primary Care, the Chinese University of Hong Kong的其他临床试验
- Effects of Behavioural Activation With Mindfulness and Physical Exercise (BAMPE) on Mental Health: A Randomized Controlled Trial
- Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial
- 慢性腰背痛症者對靜觀治療的支付意願和偏好
- Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
- 專科門診病人經驗調查 2018/19
- A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community
- Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
the Chinese University of Hong Kong的其他临床试验
- Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial
- Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial
- The effect of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Diabetic Retinal Disease
- 运动与脑刺激疗愈:促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- 一项关于声刺激增强慢波睡眠以改善失眠障碍睡眠质量的探索性研究
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
- 养老院老年人使用3D打印髋部保护器的好处
- WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构:国家市场监督管理总局 2026-09-18
-
颁布机构:国家市场监督管理总局 2026-09-17
-
颁布机构:国家市场监督管理总局 2026-08-10
